Items Tagged ‘Lung Cancer’

August 22nd, 2011

Investigational Drug Delays Progression of Non-Small Cell Lung Cancer


The investigational drug PF299804 (PF-299) improves progression-free survival compared with Tarceva® (erlotinib) among patients with advanced non-small cell lung cancer (NSCLC) that has progressed following treatment with chemotherapy. These results were recently presented at the 14th World Conference on Lung Cancer. Lung cancer remains the leading cause of cancer death in the United States. Non–small […]

View full entry

Tags: Lung Cancer, Lung Cancer - Non-Small Cell, News, Stages IIIB-IV Lung Cancer - Non-Small Cell